(Q35152674)

6 August 2017

1 reference

title

Postoperative management of differentiated thyroid cancer. (English)

1 reference

6 August 2017

Erik G Cohen

1

1 reference

6 August 2017

R Michael Tuttle

series ordinal

2

1 reference

6 August 2017

Dennis H Kraus

series ordinal

3

1 reference

6 August 2017

publication date

1 February 2003

1 reference

Otolaryngologic Clinics of North America

6 August 2017

published in

1 reference

6 August 2017

volume

36

1 reference

6 August 2017

issue

1

1 reference

6 August 2017

page(s)

129-157

1 reference

Prognostic factors for thyroid carcinoma. A population-based study of 15,698 cases from the Surveillance, Epidemiology and End Results (SEER) program 1973-1991.

6 August 2017

cites work

1 reference

https://api.crossref.org/works/10.1016%2FS0030-6665%2802%2900137-8

A National Cancer Data Base report on 53,856 cases of thyroid carcinoma treated in the U.S., 1985-1995 [see commetns]

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0030-6665%2802%2900137-8

The results of various modalities of treatment of well differentiated thyroid carcinomas: a retrospective review of 1599 patients

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0030-6665%2802%2900137-8

Papillary thyroid carcinoma: a 10 year follow-up report of the impact of therapy in 576 patients

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0030-6665%2802%2900137-8

Papillary and follicular thyroid cancer: impact of treatment in 1578 patients

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0030-6665%2802%2900137-8

External radiotherapy in thyroid cancers

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0030-6665%2802%2900137-8

Papillary thyroid carcinoma: prognostic factors and the role of radioiodine and external radiotherapy

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0030-6665%2802%2900137-8

Distant Metastases in Differentiated Thyroid Carcinoma: A Multivariate Analysis of Prognostic Variables*

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0030-6665%2802%2900137-8

Pulmonary metastasis of differentiated thyroid carcinoma: treatment results in 101 patients

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0030-6665%2802%2900137-8

Is the EORTC prognostic index of thyroid cancer valid in differentiated thyroid carcinoma? Retrospective multivariate analysis of differentiated thyroid carcinoma with long follow-up.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0030-6665%2802%2900137-8

Presidential address: beyond risk groups--a new look at differentiated thyroid cancer

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0030-6665%2802%2900137-8

Papillary and follicular thyroid cancer. Prognostic factors in 1,578 patients.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0030-6665%2802%2900137-8

Lobectomy versus total thyroidectomy for differentiated carcinoma of the thyroid: a matched-pair analysis

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0030-6665%2802%2900137-8

Long-term impact of initial surgical and medical therapy on papillary and follicular thyroid cancer

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0030-6665%2802%2900137-8

Natural history, treatment, and course of papillary thyroid carcinoma

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0030-6665%2802%2900137-8

Localized well-differentiated thyroid carcinoma: survival analysis of prognostic factors and (131)I therapy.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0030-6665%2802%2900137-8

Papillary thyroid carcinoma managed at the Mayo Clinic during six decades (1940-1999): temporal trends in initial therapy and long-term outcome in 2444 consecutively treated patients

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0030-6665%2802%2900137-8

Outcome after treatment of high-risk papillary and non-Hürthle-cell follicular thyroid carcinoma.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0030-6665%2802%2900137-8

Comparison of 30- and 50-mCi doses of iodine-131 for thyroid ablation

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0030-6665%2802%2900137-8

Low dose radioiodide thyroid ablation in postsurgical patients with thyroid cancer

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0030-6665%2802%2900137-8

Prospective randomized clinical trial to evaluate the optimal dose of 131 I for remnant ablation in patients with differentiated thyroid carcinoma

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0030-6665%2802%2900137-8

Radioiodine ablation of residual tissue in thyroid cancer: relationship between administered activity, neck uptake and outcome

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0030-6665%2802%2900137-8

Relation between effective radiation dose and outcome of radioiodine therapy for thyroid cancer

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0030-6665%2802%2900137-8

Radioiodine ablation and therapy in differentiated thyroid cancer under stimulation with recombinant human thyroid-stimulating hormone

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0030-6665%2802%2900137-8

Radioiodine ablation of thyroid remnants after preparation with recombinant human thyrotropin

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0030-6665%2802%2900137-8

Differentiated thyroid cancer. Impact of adjuvant external radiotherapy in patients with perithyroidal tumor infiltration (stage pT4).

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0030-6665%2802%2900137-8

Survival rates in patients with differentiated thyroid carcinoma. Influence of postoperative external radiotherapy

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0030-6665%2802%2900137-8

Prophylactic external irradiation in differentiated thyroid cancer: a retrospective study over a 30-year observation period

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0030-6665%2802%2900137-8

Results of external beam radiotherapy in differentiated thyroid carcinoma: a retrospective study from the Royal Marsden Hospital

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0030-6665%2802%2900137-8

Survival discriminants for differentiated thyroid cancer

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0030-6665%2802%2900137-8

Surgically incurable well-differentiated thyroid carcinoma. Prognostic factors and results of therapy

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0030-6665%2802%2900137-8

Degree of thyrotropin suppression as a prognostic determinant in differentiated thyroid cancer

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0030-6665%2802%2900137-8

Changing clinical, pathologic, therapeutic, and survival patterns in differentiated thyroid carcinoma

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0030-6665%2802%2900137-8

Thyrotropin suppression and disease progression in patients with differentiated thyroid cancer: results from the National Thyroid Cancer Treatment Cooperative Registry

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0030-6665%2802%2900137-8

The comparative value of serum thyroglobulin measurements and iodine 131 total body scans in the follow-up study of patients with treated differentiated thyroid cancer

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0030-6665%2802%2900137-8

The role of iodine-131 and thallium-201 imaging and serum thyroglobulin in the management of differentiated thyroid carcinoma

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0030-6665%2802%2900137-8

Comparison of Administration of Recombinant Human Thyrotropin with Withdrawal of Thyroid Hormone for Radioactive Iodine Scanning in Patients with Thyroid Carcinoma

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0030-6665%2802%2900137-8

The Value of Serum Thyroglobulin Measurement in Clinical Practice

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0030-6665%2802%2900137-8

Correlation of thyroglobulin measurements and radioiodine scans in the follow-up of patients with differentiated thyroid cancer

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0030-6665%2802%2900137-8

Thyroglobulin may be undetectable in the serum of patients with metastatic disease secondary to differentiated thyroid carcinoma. Follow-up of differentiated thyroid carcinoma

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0030-6665%2802%2900137-8

Low levels of serum thyroglobulin after withdrawal of thyroid suppression therapy in the follow up of differentiated thyroid carcinoma

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0030-6665%2802%2900137-8

A Comparison of Recombinant Human Thyrotropin and Thyroid Hormone Withdrawal for the Detection of Thyroid Remnant or Cancer

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0030-6665%2802%2900137-8

Immunoradiometric assay of thyroglobulin in patients with differentiated thyroid carcinomas: need for thyroglobulin recovery tests.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0030-6665%2802%2900137-8

Diagnostic value of a single serum thyroglobulin determination on and off thyroid suppressive therapy in the follow-up of patients with differentiated thyroid cancer

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0030-6665%2802%2900137-8

Preparation by recombinant human thyrotropin or thyroid hormone withdrawal are comparable for the detection of residual differentiated thyroid carcinoma

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0030-6665%2802%2900137-8

Sonography in the follow-up of 100 patients with thyroid carcinoma

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0030-6665%2802%2900137-8

High-resolution ultrasound associated with aspiration biopsy in the follow-up of patients with differentiated thyroid cancer

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0030-6665%2802%2900137-8

Ultrasound-guided fine-needle aspiration biopsy of the thyroid bed

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0030-6665%2802%2900137-8

US-guided biopsy of neck masses in postoperative management of patients with thyroid cancer

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0030-6665%2802%2900137-8

Recurrent thyroid carcinoma: characteristics on MR images

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0030-6665%2802%2900137-8

MRI detection of cervical metastasis from differentiated thyroid carcinoma

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0030-6665%2802%2900137-8

Staging papillary carcinoma of the thyroid: magnetic resonance imaging vs ultrasound of the neck

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0030-6665%2802%2900137-8

Fluorine-18 fluorodeoxyglucose positron emission tomography and iodine-131 whole-body scintigraphy in the follow-up of differentiated thyroid cancer.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0030-6665%2802%2900137-8

Fluorine-18 fluorodeoxyglucose positron emission tomography in the follow-up of differentiated thyroid cancer

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0030-6665%2802%2900137-8

Evaluation of suspected recurrent papillary thyroid carcinoma with [18F]fluorodeoxyglucose positron emission tomography

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0030-6665%2802%2900137-8

Positron emission tomography with F-18-deoxyglucose in patients with differentiated thyroid carcinoma, elevated thyroglobulin levels, and negative iodine scans.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0030-6665%2802%2900137-8

Imaging of locally recurrent and metastatic thyroid cancer with positron emission tomography

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0030-6665%2802%2900137-8

Value of preoperative diagnostic modalities in patients with recurrent thyroid carcinoma

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0030-6665%2802%2900137-8

Positron emission tomography for detecting iodine-131 nonvisualized metastasis of well-differentiated thyroid carcinoma: two case reports

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0030-6665%2802%2900137-8

Positron emission tomography for the detection of metastases of differentiated thyroid carcinoma

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0030-6665%2802%2900137-8

Utility of fluorine-18-fluorodeoxyglucose positron emission tomography in differentiated thyroid carcinoma with negative radioiodine scans and elevated serum thyroglobulin levels

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0030-6665%2802%2900137-8

The detection of small carcinoma with 18F-FDG using a dual head coincidence camera

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0030-6665%2802%2900137-8

Fluorine-18 fluorodeoxyglucose positron emission tomography in thyroid cancer: results of a multicentre study

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0030-6665%2802%2900137-8

Detection of circulating thyroid cells in peripheral blood

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0030-6665%2802%2900137-8

Detection of thyroglobulin, thyroid peroxidase, and RET/PTC1 mRNA transcripts in the peripheral blood of patients with thyroid disease

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0030-6665%2802%2900137-8

Surgical reintervention for differentiated thyroid cancer

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0030-6665%2802%2900137-8

Recurrent thyroid cancer. Role of surgery versus radioactive iodine (I131)

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0030-6665%2802%2900137-8

Management of local recurrence in well-differentiated thyroid carcinoma

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0030-6665%2802%2900137-8

The surgical management of laryngotracheal invasion by well-differentiated papillary thyroid carcinoma

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0030-6665%2802%2900137-8

Outcome of 309 patients with metastatic differentiated thyroid carcinoma treated with radioiodine

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0030-6665%2802%2900137-8

Prognostic factors in differentiated carcinoma of the thyroid gland

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0030-6665%2802%2900137-8

Radioiodine therapy for differentiated thyroid carcinoma

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0030-6665%2802%2900137-8

131I therapy in differentiated thyroid carcinoma: M. D. Anderson Hospital experience

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0030-6665%2802%2900137-8

Radioiodine treatment of metastatic thyroid carcinoma: the Royal Marsden Hospital experience

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0030-6665%2802%2900137-8

Pulmonary metastases in differentiated thyroid carcinoma. Study of 58 cases with implications for the primary tumor treatment

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0030-6665%2802%2900137-8

Evaluation of low-dose radioiodine ablation therapy in postsurgical thyroid cancer patients.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0030-6665%2802%2900137-8

inferred from DOI database lookup

7 January 2021

based on heuristic

Identifiers

DOI

10.1016/S0030-6665(02)00137-8

1 reference

6 August 2017

1 reference